Study number | Author | Time of investigation | Age (years) | Sex (M/F) | Location of investigation (province) | Questionnaires | Sample size |
Mean (SD) | |||||||
1 | Lai et al26 | 29 January–3 February | NA | 293/964 | China | PHQ-9, GAD-7, ISI and IES-R | 1257 |
2 | Liu et al23 | 1–18 February | 29.0 (5.9) | 19/1078 | Beijing, China | PHQ-9, GAD-7 and ISI | 1097 |
3 | Duan et al21 | 14–16 February | 32.8 (6.4) | 136/506 | Tianjin, China | GAD-7 and PHQ-9 | 642 |
4 | Qi et al34 | NA, submitted on 5 February | NA | 105/295 | Henan, China | SAS and SDS | 400 |
5 | Huang et al44 | 7–14 February | 32.6 (6.2) | 43/187 | Anhui, China | SAS and PTSD-SS | 230 |
6 | Zhang et al41 | 29 January–6 February | NA | 56/168 | Hubei, China | SAS and SDS | 224 |
7 | Zeng et al43 | NA, submitted on 20 February | NA | NA | Hunan, China | SAS and CPSS | 152 |
8 | Wu et al39 | NA, submitted on 2 February | 30.8 (4.5) | 21/85 | Sichuan, China | SAS and PSQI | 106 |
9 | Huang and Ke40 | NA, submitted on 10 February | 38.3 (11.9) | 18/32 | Guangdong, China | SAS | 50 |
10 | Wang et al30 | 30 January–7 February | 33.8 (8.4) | 12/111 | Hubei, China | PSQI, SAS and SDS | 123 |
11 | Lu et al28 | 25–26 February | NA | 451/1591 | Fujian, China | HAMD and HAMA | 2042 |
12 | Cao et al20 | NA, submitted on 26 February | 32.8 (9.6) | NA | Beijing, China | PHQ-9 and MBI | 37 |
13 | Chen et al24 | 10–20 February | 32.6 (6.5) | NA | Guizhou, China | SDS and SAS | 105 |
14 | Du et al25 | 13–17 February | 36.0 (8.1) | NA | Hubei, China | BDI-II, BAI and PSS | 134 |
15 | Li et al27 | 8–15 February | NA | 0/4369 | Shanghai, China | PHQ-9, GAD-7 and IES-R | 4369 |
16 | Ni et al29 | 16–24 February | NA | NA | Hubei, China | GAD-2 and PHQ-2 | 214 |
17 | Zhang et al31 | 29 January–3 February | NA | 1293/270 | China | ISI, PHQ-9, GAD-7 and IES-R | 1563 |
18 | Zhang et al10 | 19 February–6 March | NA | 249/678 | China | ISI, GAD-2 and PHQ-2 | 927 |
19 | Huang and Zhao32 | 3–17 February | NA | NA | China | GAD-7, CES-D and PSQI | 2250 |
20 | Chen et al33 | NA, submitted on 22 February | NA | NA | Sichuan, China | SAS | 173 |
21 | Chen et al35 | 3–16 February | NA | 315/396 | Zhejiang, China | PHQ-9 and GAD-7 | 711 |
22 | Wei et al22 | 10–20 February | NA | 873/1277 | Shanghai, China | PHQ-9, GAD-7 and PSQI | 2150 |
23 | Xu et al42 | 7–15 February | 34.8 (7.1) | 69/291 | Anhui, China | SAS and SDS | 360 |
24 | Ye et al37 | 29 January–5 February | NA | 460/1644 | Sichuan, China | GAD-7 | 2104 |
25 | Zhen et al38 | 18–21 February | NA | 95/278 | Zhejiang, China | PSS-10 and PHQ-9 | 373 |
26 | Li et al36 | 8–11 February | NA | 30/175 | Hubei, China | PCL-C | 205 |
BAI, Beck Anxiety Inventory; BDI-II, Beck Depression Inventory-II; CES-D, Centre for Epidemiological Studies Depression Scale; CPSS, Chinese Perceived Stress Scale; GAD-2, Generalised Anxiety Disorder-2; GAD-7, Generalised Anxiety Disorder-7; HAMA, Hamilton Anxiety Scale; HAMD, Hamilton Depression Scale; IES-R, Impact of Events Scale—Revised; ISI, Insomnia Severity Index; MBI, Maslach Burn-out Inventory; NA, not applicable; PCL-C, PTSD Checklist—Civilian Version; PHQ-2, Patient Health Questionaire-2; PHQ-9, Patient Health Questionaire-9; PSQI, Pittsburgh Sleep Quality Index; PSS, Perceived Stress Scale; PTSD-SS, Post-Traumatic Stress Disorder Self Rating Scale; SAS, Self-rating Anxiety Scale; SDS, Self-rating Depression Scale; SQR-20, Self-reporting Questionnaires 20.